Virtual
GSK Vaccines Virtual Days 2023
Mar 29-30, 2023
Conferences
Please visit scientific meetings and events where GSK Vaccines will have a presence
Material supplied by the above-country business unit to LOCs for localisation must be subject to local Medical and/or Regulatory review and approval prior to use and/or external distribution.
LOCs to insert local adverse events reporting procedure.
© 2022 GSK group of companies or its licensor. GlaxoSmithKline Biologicals SA. Rixensart, Belgium.
NX-GBL-GVX-WCNT-210012 | December 2022